EmeritusDX Acquires Freedom Pathology Partners
June 13, 2022
EmeritusDX, a cancer diagnostics and information company, has acquired Freedom Pathology Partners, a CAP- and CLIA-accredited laboratory based in Conshohocken, Pennsylvania. The acquisition expands EmeritusDX’s national presence and test menu—adding anatomic pathology, FISH, and molecular testing capabilities and strengthening relationships in dermatology, gastroenterology, and urology markets.
- Buyers
- EmeritusDX
- Targets
- Freedom Pathology Partners
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
EmeritusDX Acquires Sprint Diagnostics
July 2, 2024
Healthcare Services
EmeritusDX, a cancer diagnostics and information company, has entered a definitive agreement to acquire Sprint Diagnostics to expand its Pharma Services Division. The acquisition adds advanced diagnostic capabilities and laboratory production capacity to EmeritusDX's CLIA-certified operations, supporting growth in pharmaceutical and clinical trial services.
-
LabGenomics USA LLC Acquires QDx Pathology
September 5, 2023
Healthcare Services
LabGenomics USA LLC, a subsidiary of South Korea–based LabGenomics Co., Ltd., has acquired QDx Pathology, a U.S. clinical and molecular pathology laboratory. The deal, signed in August 2023, is intended to accelerate LabGenomics' entry and expansion into the North American diagnostics market by combining QDx's lab services with LabGenomics' NGS-based molecular diagnostics capabilities.
-
Fulgent Genetics Acquires Inform Diagnostics from Avista Capital Partners
April 18, 2022
Healthcare Services
Fulgent Genetics agreed to acquire Inform Diagnostics, a leading national independent pathology laboratory headquartered in Irving, Texas, for approximately $170 million. The acquisition from Avista Capital Partners expands Fulgent’s pathology and anatomic testing menu, adds nationwide commercial and managed-care relationships, and broadens its geographic lab footprint to support cross-selling of genomic and pathology services.
-
FUJIFILM Acquires Inspirata's Digital Pathology Business
December 19, 2022
Healthcare Services
FUJIFILM Corporation entered into an asset purchase agreement to acquire the global digital pathology business of Tampa-based Inspirata, Inc., including the Dynamyx technology, associated employees and customers. The acquisition expands FUJIFILM's Synapse Enterprise Imaging portfolio to add digital pathology capabilities and support integration of pathology images and data across healthcare organizations.
-
Synergy Laboratories Acquires Pathology Laboratory Associates
March 3, 2020
Healthcare Services
Synergy Laboratories, a Mobile, Alabama-based clinical laboratory, has acquired Mobile-based Pathology Laboratory Associates (PLA). The acquisition expands Synergy's pathology and women’s health testing capabilities, with PLA remaining headquartered on the Springhill Medical Center campus and plans to grow staffing and specialized pathology services.
-
Versant Diagnostics Acquires Two Chicago-Area Pathology Practices
July 11, 2022
Healthcare Services
Versant Diagnostics, a PE-backed independent physician services company, acquired Pathology Consultants of Chicago and the operating assets of Elgin Laboratory Physicians to expand its footprint in the greater-Chicago market. The deals (Versant's third and fourth acquisitions in nine months) support the company's strategy to consolidate pathology practices and accelerate digital pathology conversion with growth capital backing from Iron Path Capital and financing support from Principal.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.